GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » EV-to-EBIT

OLYMY (Olympus) EV-to-EBIT : 18.43 (As of May. 21, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Olympus EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Olympus's Enterprise Value is $14,317 Mil. Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $777 Mil. Therefore, Olympus's EV-to-EBIT for today is 18.43.

The historical rank and industry rank for Olympus's EV-to-EBIT or its related term are showing as below:

OLYMY' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.12   Med: 25.14   Max: 91.86
Current: 18.43

During the past 13 years, the highest EV-to-EBIT of Olympus was 91.86. The lowest was 12.12. And the median was 25.14.

OLYMY's EV-to-EBIT is ranked better than
54.35% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 19.665 vs OLYMY: 18.43

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Olympus's Enterprise Value for the quarter that ended in Dec. 2024 was $16,791 Mil. Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $777 Mil. Olympus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 4.63%.


Olympus EV-to-EBIT Historical Data

The historical data trend for Olympus's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus EV-to-EBIT Chart

Olympus Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.96 20.69 16.10 54.84 13.02

Olympus Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.84 59.27 27.37 22.91 -

Competitive Comparison of Olympus's EV-to-EBIT

For the Medical Devices subindustry, Olympus's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Olympus's EV-to-EBIT falls into.


;
;

Olympus EV-to-EBIT Calculation

Olympus's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=14317.024/776.911
=18.43

Olympus's current Enterprise Value is $14,317 Mil.
Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $777 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus  (OTCPK:OLYMY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Olympus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=776.911/16791.03992
=4.63 %

Olympus's Enterprise Value for the quarter that ended in Dec. 2024 was $16,791 Mil.
Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $777 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Olympus's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.